KIR3DL1 and melanoma: In one study, KIR3DL1 and KIR2DL3 were expressed at higher levels on the NK cells of melanoma patients [227], while other studies found an increase in KIR2DL1 [228,229] and KIR2DL2/2DL3 [46,230].